menu
    • menu

    Company profile for Formation Bio

    NEW Drugs in Dev: 4
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Formation Bio stands out as a tech-forward pharmaceutical enterprise, streamlining drug development with unparalleled efficiency. Their proprietary technology platform revolutionizes clinical trials, enhancing design, hastening completion, and elevating data quality. By acquiring clinical-stage drugs, they expedite development, aiming to swiftly bring new treatments to patients and maximize program value.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Formation BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    16 E 34th Street Fl 10 New York
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.formation.bio/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/formationbio
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Paris Packaging Week

    Paris Packaging Week

    Not Confirmed

    envelop Contact Supplier

    Paris Packaging Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Formation Bio Licenses MIR-124 Activator For Autoimmune Diseases
    Formation Bio Licenses MIR-124 Activator For Autoimmune Diseases

    29 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formation-bio-licenses-mir-124-activator-for-autoimmune-diseases-from-ctfh-302673553.html

    PR NEWSWIRE
    29 Jan 2026
    Share Share
    Lynk Pharma, Formation Bio Ink Exclusive Deal For LNK01006
    Lynk Pharma, Formation Bio Ink Exclusive Deal For LNK01006

    10 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-and-formation-bio-enter-exclusive-development-and-licensing-agreement-for-lnk01006-302637950.html

    PR NEWSWIRE
    10 Dec 2025
    Share Share
    Formation Boosts Leadership Team for AI-Driven Drug Development
    Formation Boosts Leadership Team for AI-Driven Drug Development

    18 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formation-bio-expands-leadership-team-with-top-biotech-and-pharma-executives-to-accelerate-ai-driven-drug-development-302560861.html

    PR NEWSWIRE
    18 Sep 2025
    Share Share
    Formation Bio Licenses Anti-CD226 Program from IMIDomics
    Formation Bio Licenses Anti-CD226 Program from IMIDomics

    29 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formation-bio-licenses-first-in-class-anti-cd226-autoimmune-program-from-imidomics-302515217.html

    PR NEWSWIRE
    29 Jul 2025
    Share Share
    Sanofi Signs €545M Deal to Explore Formation’s JAK/SYK Inhibitor
    Sanofi Signs €545M Deal to Explore Formation’s JAK/SYK Inhibitor

    24 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/libertas-bio-a-formation-bio-subsidiary-license-of-gusacitinib-a-dual-jaksyk-inhibitor-to-sanofi-302487403.html

    PR NEWSWIRE
    24 Jun 2025
    Share Share
    Formation Bio Names First Entrepreneurs in Residence Class
    Formation Bio Names First Entrepreneurs in Residence Class

    09 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formation-bio-announces-first-class-of-entrepreneurs-in-residence-to-drive-pipeline-growth-and-strategic-partnerships-302476651.html

    PR NEWSWIRE
    09 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search